rs1613662

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_016363.5(GP6):​c.655C>T​(p.Pro219Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.84 in 1,541,374 control chromosomes in the GnomAD database, including 544,761 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.83 ( 53189 hom., cov: 31)
Exomes 𝑓: 0.84 ( 491572 hom. )

Consequence

GP6
NM_016363.5 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.373

Publications

122 publications found
Variant links:
Genes affected
GP6 (HGNC:14388): (glycoprotein VI platelet) This gene encodes a platelet membrane glycoprotein of the immunoglobulin superfamily. The encoded protein is a receptor for collagen and plays a critical role in collagen-induced platelet aggregation and thrombus formation. The encoded protein forms a complex with the Fc receptor gamma-chain that initiates the platelet activation signaling cascade upon collagen binding. Mutations in this gene are a cause of platelet-type bleeding disorder-11 (BDPLT11). Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011]
GP6-AS1 (HGNC:55305): (GP6 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.3788144E-6).
BP6
Variant 19-55025227-G-A is Benign according to our data. Variant chr19-55025227-G-A is described in ClinVar as Benign. ClinVar VariationId is 257422.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.953 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GP6NM_016363.5 linkc.655C>T p.Pro219Ser missense_variant Exon 5 of 8 ENST00000417454.5 NP_057447.5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GP6ENST00000417454.5 linkc.655C>T p.Pro219Ser missense_variant Exon 5 of 8 1 NM_016363.5 ENSP00000394922.1

Frequencies

GnomAD3 genomes
AF:
0.834
AC:
126869
AN:
152052
Hom.:
53163
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.774
Gnomad AMI
AF:
0.770
Gnomad AMR
AF:
0.887
Gnomad ASJ
AF:
0.795
Gnomad EAS
AF:
0.976
Gnomad SAS
AF:
0.787
Gnomad FIN
AF:
0.890
Gnomad MID
AF:
0.848
Gnomad NFE
AF:
0.846
Gnomad OTH
AF:
0.846
GnomAD2 exomes
AF:
0.854
AC:
133645
AN:
156582
AF XY:
0.848
show subpopulations
Gnomad AFR exome
AF:
0.763
Gnomad AMR exome
AF:
0.922
Gnomad ASJ exome
AF:
0.796
Gnomad EAS exome
AF:
0.981
Gnomad FIN exome
AF:
0.886
Gnomad NFE exome
AF:
0.840
Gnomad OTH exome
AF:
0.842
GnomAD4 exome
AF:
0.840
AC:
1167289
AN:
1389204
Hom.:
491572
Cov.:
30
AF XY:
0.840
AC XY:
575866
AN XY:
685906
show subpopulations
African (AFR)
AF:
0.764
AC:
23993
AN:
31386
American (AMR)
AF:
0.918
AC:
32823
AN:
35768
Ashkenazi Jewish (ASJ)
AF:
0.794
AC:
19919
AN:
25092
East Asian (EAS)
AF:
0.981
AC:
35039
AN:
35724
South Asian (SAS)
AF:
0.790
AC:
62447
AN:
79050
European-Finnish (FIN)
AF:
0.884
AC:
43679
AN:
49418
Middle Eastern (MID)
AF:
0.802
AC:
4495
AN:
5602
European-Non Finnish (NFE)
AF:
0.838
AC:
896390
AN:
1069424
Other (OTH)
AF:
0.840
AC:
48504
AN:
57740
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
8784
17567
26351
35134
43918
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20454
40908
61362
81816
102270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.834
AC:
126955
AN:
152170
Hom.:
53189
Cov.:
31
AF XY:
0.839
AC XY:
62391
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.773
AC:
32084
AN:
41480
American (AMR)
AF:
0.887
AC:
13552
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.795
AC:
2761
AN:
3472
East Asian (EAS)
AF:
0.976
AC:
5062
AN:
5188
South Asian (SAS)
AF:
0.786
AC:
3789
AN:
4820
European-Finnish (FIN)
AF:
0.890
AC:
9444
AN:
10610
Middle Eastern (MID)
AF:
0.850
AC:
250
AN:
294
European-Non Finnish (NFE)
AF:
0.846
AC:
57532
AN:
68018
Other (OTH)
AF:
0.845
AC:
1782
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1058
2116
3173
4231
5289
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
888
1776
2664
3552
4440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.839
Hom.:
242917
Bravo
AF:
0.832
TwinsUK
AF:
0.837
AC:
3105
ALSPAC
AF:
0.836
AC:
3223
ESP6500AA
AF:
0.779
AC:
2935
ESP6500EA
AF:
0.847
AC:
6850
ExAC
AF:
0.765
AC:
61765
Asia WGS
AF:
0.884
AC:
3076
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 31699788, 11571236, 22133274, 19786296, 25525159, 20227257, 21232005, 20723028, 18349091, 19278955) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Platelet-type bleeding disorder 11 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-0.86
T
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.39
DANN
Benign
0.25
DEOGEN2
Benign
0.020
T;.
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.0023
N
MetaRNN
Benign
0.0000014
T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
-0.11
N;N
PhyloP100
-0.37
PrimateAI
Benign
0.28
T
PROVEAN
Benign
0.18
N;N
REVEL
Benign
0.0080
Sift
Benign
0.76
T;T
Sift4G
Benign
0.91
T;T
Polyphen
0.0
B;B
Vest4
0.095
MPC
0.16
ClinPred
0.00058
T
GERP RS
-0.22
Varity_R
0.021
gMVP
0.11
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1613662; hg19: chr19-55536595; COSMIC: COSV59979323; COSMIC: COSV59979323; API